Histopathological examination of a percutaneous transthoracic lung biopsy (PTLB) revealed adenocarcinoma (programmed cell death 1 ligand 1, PD-L1 95%; tumor mutation burden, TMB 9.4). The gene discussed is CD274; the disease is neoplasm.